# RetinalGenix Technologies Inc. (RTGN)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RTGN/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -897.9K | $ -245.9K | $ 54.6K | $ -2.64M |
| 2025 | $ 0 | $ -2.49M | $ -571.7K | $ 55.5K | $ -2.30M |
| 2024 | $ 105 | $ -4.54M | $ -779.8K | $ 56.5K | $ -1.46M |
| 2023 | $ 162 | $ -2.26M | $ -376.7K | $ 49.0K | $ -1.41M |
| 2022 | $ 0 | $ -6.32M | $ -223.0K | $ 49.0K | $ -1.07M |
| 2021 | $ 154.3K | $ -2.77M | $ -1.39M | $ 73.0K | $ -464.7K |
| 2020 | $ 0 | $ -2.69M | $ -1.81M | $ 0 | $ -80.4K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -0.02 |
| Liabilities / Eq | -1.01 |
| Current Ratio | 0.01 |

## Other views

- [Metrics](https://sponda.capital/en/RTGN.md)
- [Charts](https://sponda.capital/en/RTGN/charts.md)
- [Compare](https://sponda.capital/en/RTGN/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.